FMA
NITE

FNY Managed Accounts’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

FNY Managed Accounts’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,440
Closed -$66K – 913
2017
Q3 		$66K Buy
+3,440
New +$74.3K 0.09% 142

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

FNY Managed Accounts's NITE Position: Q4 2017 in Review

FNY Managed Accounts sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 3,440 shares — an estimated $66K sold.

FNY Managed Accounts first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $66K in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • FNY Managed Accounts reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 3,440 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $66K.
  • FNY Managed Accounts first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Nightstar Therapeutics plc American Depositary Shares position peaked at $66K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on FNY Managed Accounts's 13F filing for Q4 2017, filed 23 Jan 2018.